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The devastating genetic disorder Cockayne syndrome (CS) arises from mutations in the CSA and CSB genes. CS
is characterized by progressive multisystem degeneration and is classified as a segmental premature-aging syndrome.
The CS complementation group B (CSB) protein is at the interface of transcription and DNA repair and is involved
in transcription-coupled and global genome–DNA repair, as well as in general transcription. Recent structure-
function studies indicate a process-dependent variation in the molecular mechanism employed by CSB and provide
a starting ground for a description of the mechanisms and their interplay.
Introduction
Patients with Cockayne syndrome (CS [MIM 133540 and
MIM 216400]) are characterized by traits reminiscent
of normal aging, such as systemic growth failure, neu-
rological degeneration, and cataracts; CS has thus been
classified as a segmental premature-aging syndrome. The
majority of CS cases are caused by defects in the CS
complementation group B (CSB) protein, which is also
the factor we focus on in this review article. CS can be
described as “a transcription- and DNA repair–defi-
ciency syndrome.”
Cellular DNA is exposed to various endogenous and
exogenous damaging agents. The inflicted lesions are
normally repaired by the different pathways of DNA
repair. However, not all lesions are removed, and it has
been suggested that a gradual accumulation of DNA
lesions during the cellular and organismal lifetime con-
tributes to the normal aging process. Among the major
DNA repair pathways are nucleotide-excision repair
(NER) and base-excision repair (BER), both responsible
for excising and repairing different lesions in DNA (re-
viewed by Friedberg et al. [1995]). NER is effective on
bulky adducts and intrastrand cross links, whereas BER
recognizes single-strand breaks and minor base lesions,
such as oxidative modifications and methylations.
NER can be divided in global genome repair (GGR)
and transcription-coupled repair (TCR), depending on
the primary damage-recognition step. TCR is the pref-
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erential repair of the transcribed strand of active genes,
where lesion-induced stalling of the transcribing RNA
polymerase serves as a signal for recruitment of factors
responsible for NER (Bohr et al. 1985; Mellon et al.
1987). GGR is, as implied by the name, the repair of
lesions situated in all regions of the genome, and the
lesion recognition is mediated by a combination of the
factors XPC/hHR23B (MIM 278720 and MIM 600062),
replication protein A (RPA [MIM 179835]), and XPA
(MIM 278700). Many NER factors have been discovered
through studies of the seven complementation groups of
the genetic disorder xeroderma pigmentosum (XP [MIM
278700]) and are thus named “XPA,” “XPB” (MIM
133510), “XPC,” “XPD” (MIM 278730), “XPE” (MIM
278740), “XPF” (MIM 133520), and “XPG” (MIM
133530). Apart from XPC/hHR23B and XPE, which are
specific to global genome NER (GG-NER), all NER
factors are common to TCR and GGR. XPC, XPA, and
RPA are responsible for recognizing and ascertaining the
DNA lesion and provide binding sites for additional NER
factors. The XPB and XPD helicase subunits of TFIIH
(MIM 189972) unwind the DNA around the lesion, and
the two structure-specific endonucleases XPG and XPF/
ERCC1 (MIM 126380) make single-strand incisions 3′
and 5′ to the DNA lesion, respectively. An ∼28-base patch
of DNA that contains the damaged site is thus excised,
and the repair pathway is completed by DNA resynthesis
by use of the undamaged complementary strand as
template.
In BER, damaged bases are recognized by various
DNA glycosylases, each with specific yet overlapping le-
sion targets. The DNA glycosylase is responsible for re-
moving its cognate aberrant base by hydrolysis of the N-
glycosylic bond. This step is succeeded by cleavage of the
DNA backbone and removal of the remaining deoxyri-
bose moiety by an endonuclease activity, pertaining either
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Figure 1 Summary of CSB cellular phenotypes: the responses of CSB cells to various DNA damaging agents and the underlying cellular
processes affected.
to the DNA glycosylase or to APE1 (MIM 107748). Fi-
nally, a resynthesis step of 1–7 bases, depending on the
subpathway employed, restores the integrity of DNA.
The CSB protein seems to be involved in several dif-
ferent processes, including transcription by RNA poly-
merase I (MIM 602000), II (MIM 180660), and possibly
III (MIM 606007), transcription-coupled NER, and BER
of some types of oxidative damage in nuclei and mito-
chondria (summarized in fig. 1). Apparently, CSB em-
ploys different mechanisms of action, depending on the
functional context. The involvement of CSB in transcrip-
tion, TCR, and BER might be simultaneous; yet, some
kind of interregulation, depending on cellular status, is
suspected to be a functional advantage of a common key
factor in these processes. It could be through posttrans-
lational modifications of CSB and changes in function
and localization of its interaction partners. The many
roles of CSB provide an explanation for the multisystem
manifestations of the CS phenotype (see below) and pro-
vide rich ground for the influence of genetic background,
which explains the phenotypic diversity of patients with
CS.
CS: Clinical Manifestations
CS is a rare genetic disorder with autosomal recessive
inheritance. It is characterized by growth failure and
multisystem progressive degeneration (Cockayne 1936;
Nance and Berry 1992). More than 180 cases of CS have
been reported from different parts of the world, with no
apparent overrepresentation in any specific population
(Nance and Berry 1992; Colella et al. 1999; Mahmoud
et al. 2002). Different genotypes have been found to un-
derlie CS. Of patients with CS, ∼80% have mutations in
the CSB gene, whereas the remaining patients carry mu-
tated CSA (MIM 216400) alleles. Mutations in the XPB,
XPD, or XPG genes from XP group B, D, and G, re-
spectively, are detected in patients with a combined XP/
CS phenotype (reviewed by de Boer and Hoeijmakers
[2000] and Rapin et al. [2000]).
Patients with CS display variable phenotypes with
respect to age at onset, symptoms displayed, and se-
verity of the defects. However, signs of poor growth and
neurological abnormalities are required for diagnosis.
Growth failure is evident in height and weight, since few
patients with CS exceed 115 cm in height and 20 kg in
weight. Usually, weight is more affected than height,
which leads to the term “cachectic dwarfism.” Neuro-
logical abnormalities are caused by progressive neuro-
degeneration and include delayed psychomotor develop-
ment, mental retardation—measured with formal intelli-
gence testing—and microcephaly in most patients. Gait
ataxia, which indicates cerebellar dysfunction, also may
be evident. Neuropathological examinations have shown
multifocal patchy demyelination in the cerebral and cer-
ebellar cortex, dilated ventricles, and calcium deposits in
basal ganglia and cerebral cortex (Itoh et al. 1999; Brooks
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2002). Loss of neurons was seen to a moderate degree
in the vicinity of calcium deposits but was most evident
throughout the cerebellum (Itoh et al. 1999). Thus, the
neurological defects in CS seem to be associated with
widespread demyelination of the CNS and neuronal loss
in the cerebellum. Changes in glutamate transport and
accumulation of oxidative products in the globus pal-
lidus have also been reported (Hayashi et al. 2001). In
addition, peripheral nerve defects have been detected as
reduced velocity of nerve conduction, sensorineural
hearing loss, and changes in muscle innervations (Nance
and Berry 1992; Rapin et al. 2000; Lindenbaum et al.
2001).
Many patients display structural eye abnormalities,
such as cataracts and pigmentary degeneration of the
retina, and ciliary body defects (Dollfus et al. 2003). An-
other very prominent symptom in patients with CS is
cutaneous photosensitivity manifested as an unusually
high ultraviolet (UV) sensitivity, with resulting pigmen-
tation abnormalities and general atrophy of sun-exposed
skin (Nance and Berry 1992; Rapin et al. 2000). This is
not associated with an increased risk of skin cancer. Re-
duced amounts of subcutaneous fat are often seen and
contribute to the characteristic facial appearance of pa-
tients with CS, often called “birdlike face”: enophthalmia
(sunken eyes), a beaked nose, and a narrow mouth
(Nance and Berry 1992; Dollfus et al. 2003). Patients
with CS also display dental caries and skeletal abnor-
malities such as kyphosis. The progressive degeneration
seen in individuals with CS does not affect immune func-
tion and is not associated with an elevated cancer risk.
The life expectancy is 12.5 years, but the individual age
at death spans the spectrum from neonatal to (in one
patient) age 55 years. The most common cause of death,
pneumonia, is probably a result of general atrophy and
cachexia.
As mentioned above, CS can be caused by mutations
in five different genes, with the majority of cases attrib-
utable to CSB. Mutations in CSB, on the other hand,
have also been associated with two other phenotypes,
cerebro-oculo-facio-skeletal syndrome (MIM 214150)
(Meira et al. 2000) and the DeSanctis-Cacchione severe
neurological form of XP (MIM 278800) (Colella et al.
2000). Nine patients have so far been reported with the
combined phenotype XP/CS: three with XPB/CS, two
with XPD/CS, and four with XPG/CS (Rapin et al.
2000). The patients with XPD/CS and XPG/CS display
a severe CS phenotype, whereas the patients with XPB/
CS have very mild symptoms. Furthermore, presumably
identical mutations in genes that cause CS can result in
different phenotypes (Colella et al. 2000; Mahmoud et
al. 2002). Thus, the genotype-phenotype relationships
of these disorders and the involved genes are complex.
CSB Cellular Characteristics
Mammalian CSB studies are typically performed using
hamster, mouse, or human cells. Aspects of the CSB cel-
lular phenotype are shown in figure 1. Some rodent cells,
including Chinese hamster ovary (CHO) cells, have very
limited GGR of UV-induced cyclobutane pyrimidine di-
mers (CPD) compared with human cells. CSB studies in
hamster cells are mainly performed using the UV61 cell
line, which is defective in the hamster CSB homologue
and which was originally used to clone the human gene
for CSB (Troelstra et al. 1992). UV61 cells have been
used for studies in structure-function relationships (Brosh
et al. 1999; Sunesen et al. 2000, 2002) and apoptosis
(Balajee et al. 2000; Proietti De Santis et al. 2001, 2002).
Since the construction of a csb/ mouse in 1997 (van
der Horst et al. 1997), studies of liver cells, mouse em-
bryonic fibroblasts (MEF), keratinocytes, and embryonic
stem (ES) cells from isogenic mice have been undertaken
(Osterod et al. 2002; Stevnsner et al. 2002; de Waard
et al. 2003). CSB knockout mice display a phenotype
resembling that of patients with CS, with mild growth-
related and neurological defects and a surprising pre-
disposition to skin cancer (van der Horst et al. 1997).
CSB studies in human cells have been conducted with
primary and SV40-transformed fibroblasts and with pri-
mary lymphoblastoid cells derived from patients with
CS. The most frequently used cells are primary or SV40-
transformed cells from patient CS1AN. The SV40-trans-
formed cell line, CS1AN.S3.G2, has CSB alleles with
ArT transversions at nucleotide 1088 that result in a
stop codon at position 337 of the CSB protein (Troelstra
et al. 1992). Studies using these cells must take into
account the SV40-induced increased chromosomal in-
stability and lack of p53 (MIM 191170) activity.
Hamster UV61 cells, csb/ MEFs from Csb knockout
mice, and primary as well as transformed CSB fibro-
blasts are hypersensitive to UV light (Wade and Chu
1979; Troelstra et al. 1992; van der Horst et al. 1997;
Sunesen et al. 2000). UV irradiation induces primarily
two types of lesions in DNA: CPDs, mainly removed
by TCR, and pyrimidine 6-4 pyrimidone photoprod-
ucts, predominantly removed by GGR. Transfection of
UV61 and CS1AN.S3.G2 cells with wild-type (WT) CSB
cDNA restores the UV sensitivity to a WT level (Troel-
stra et al. 1992; Orren et al. 1996; Brosh et al. 1999).
UV doses of 5–10 J/m2 result in a significant reduction
in survival of CSB cells compared with WT cells. A hy-
persensitivity toward 4-nitroquinoline-1-oxide (4-NQO)
has been shown for primary and SV40-transformed
CS1AN fibroblasts (Wade and Chu 1979; Tuo et al. 2001;
Muftuoglu et al. 2002). 4-NQO induces alkali-labile sin-
gle-strand DNA (ssDNA) breaks and bulky adducts re-
paired without strand bias (Snyderwine and Bohr 1992).
Another DNA-damaging agent, N-acetoxy-2-acetylami-
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nofluorene (NA-AAF), inducing the lesion N-(deoxy-
guanosine-8-yl)-2-acetylaminofluorene (dG-C8-AAF)
repaired by GGR (Tang et al. 1989), effects a reduced
survival in primary CS1AN cells compared with WT
cells (Wade and Chu 1979; van Oosterwijk et al. 1998).
This hypersensitivity has also been shown in UV61 cells
(Sunesen et al. 2000).
Ionizing radiation (IR) induces ssDNA breaks, double-
strand DNA (dsDNA) breaks, and oxidative base dam-
age. Primary and transformed CS1AN cells exposed to
g radiation have an ∼50% reduction in clonogenic sur-
vival compared with WT cells (Leadon and Cooper
1993; Tuo et al. 2001). The effect of IR on CSB-deficient
cells has been ascribed to induced oxidative damage.
However, Selzer et al. (2002) report no major difference
in survival after H2O2, when comparing CS1AN.S3.G2
and WT cells (Selzer et al. 2002). Results of a recent
study investigating the effect of IR on the clonogenic
survival of MEFs, ES cells, and keratinocytes from csb
knockout mice show a marked reduction in survival of
csb/ MEFs only, compared with WT cells (de Waard
et al. 2003). The csb/ MEFs were also found to be
hypersensitive to paraquat (which generates superoxide)
and H2O2 (causative of oxidative damage to DNA). de
Waard et al. (2003) have therefore suggested that the
hypersensitivity to IR seen in csb/ MEFs is due to oxi-
dative base damage (de Waard et al. 2003).
A characteristic cellular phenotype of CSB cells is the
deficient recovery of RNA synthesis after exposure to
UV (Troelstra et al. 1992; van der Horst et al. 1997).
RNA synthesis in normal cells is transiently inhibited
following UV exposure, but, unlike CSB cells, they re-
cover to 90% of pretreatment levels within 90 min
(Mayne 1984). The defect in recovery of RNA synthesis
after UV irradiation is thought to reflect a defect in TCR
(Troelstra et al. 1992). Primary CS1AN fibroblasts are
also deficient in recovery of RNA synthesis after treat-
ment with paraoxon/NA-AAF compared with WT cells
(van Oosterwijk et al. 1998), which is surprising, since
the inflicted damage is repaired by GGR. The same situa-
tion applies to 4-NQO in UV61 cells (Brosh et al. 1999).
Balajee et al. (1997) have shown a 50% reduction in
transcription in intact and permeabilized CSB fibro-
blasts and lymphoblasts. This defect is ascribed to a
defect in elongation of transcription. A recent study im-
plicates CSB in rRNA synthesis by RNA polymerase I:
recombinant CSB stimulates rRNA synthesis 10-fold in
vitro, and CSB cells have an apparently reduced rRNA
synthesis rate in vivo, which is associated with a reduced
growth rate (Bradsher et al. 2002).
Analyses of differential gene expression in CSB and
WT cells by use of an array technique have recently been
reported. Selzer et al. (2002) compared expression pro-
files in CS1AN.S3.G2 fibroblasts transfected with vector
alone or vector carrying the CSB WT allele, but they
did not find any significant change (Selzer et al. 2002).
Kyng et al. (2003) compared the expression profile of
6,912 genes after H2O2-inflicted oxidative stress for
CSB-deficient and CSB-rescued SV40-transformed fi-
broblasts (Kyng et al. 2003). CSB-deficient cells, in re-
sponse to H2O2, had a differential expression of 122
genes, compared with WT rescued cells. The down-
regulated genes in the CSB-deficient cells encompassed
genes encoding uracil-DNA glycosylase (UNG [MIM
191525]), heat-shock proteins, cell-cycle–related pro-
teins, and ribosomal proteins (Kyng et al. 2003).
Another characteristic cellular feature of CSB cells is
their predisposition to undergo apoptosis in response to
UV treatment (Ljungman and Zhang 1996). Induction
of apoptosis after UV or cisplatin treatment is associated
with an accumulation of active p53 and inhibition of
total RNA synthesis (Ljungman and Zhang 1996;
Ljungman et al. 1999). Specific inhibition of RNA poly-
merase II by various agents leads to the same response
(Ljungman et al. 1999). Balajee et al. (2000) showed
that a mutated CSB gene is directly responsible for the
propensity to UV-induced apoptosis in CSB cells (Ba-
lajee et al. 2000). Inhibition of replication by use of
aphidicolin does not induce apoptosis in the normal
hamster AA8 cells, whereas transcription inhibition by
a-amanitin does (Balajee et al. 2000). CSB has been
suggested to exert an antiapoptotic effect after UV treat-
ment by preventing blockage of RNA Pol II transcrip-
tion by UV-induced DNA damage (Ljungman et al. 1999;
Balajee et al. 2000). The tumor suppressor protein p53
is induced at lower UV doses in CSB cells than in normal
human fibroblasts, and the induction lasts longer (Ba-
lajee et al. 2000). It is possible that UV-induced apop-
tosis can be independent of p53 (Spivak et al. 2003).
This is also suggested by the increased propensity to
UV-induced apoptosis in UV61 cells, which have a mu-
tated p53. Reports indicate that progression into and/
or through S phase after UV treatment is necessary to
induce apoptosis (Proietti De Santis et al. 2001, 2002;
McKay et al. 2002). At low UV doses, CSB cells, owing
to their impaired TCR, retain more damage than normal
cells and are predisposed to undergo apoptosis after S
phase entry. At high UV doses, the damage to CSB cells
could be so devastating that entry into S phase is in-
hibited and apoptosis reduced compared with normal
cells that, have a functional TCR, and can repair some
of the damage and proceed into S phase and pro-
grammed cell death (McKay et al. 2002).
Studies by Tuo et al. (2001) show that CSB-deficient
human cells accumulate oxidative damage, compared
with WT cells, after treatment with g radiation. They
find significant accumulation of the oxidative purine
modifications 8-hydroxy-7,8-dihydroguanine (8-oxoG)
(Tuo et al. 2001) and 8-hydroxy-7,8-dihydroadenine (8-
oxoA) (Tuo et al. 2002b). These studies detect no sig-
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nificant difference in accumulation of endogenous oxi-
dative damage in the CSB-proficient and -deficient fibro-
blasts tested (Tuo et al. 2001, 2002b). However, csb//
ogg1 (8-oxoguanine DNA glycosylase 1 or ogg1/ [MIM
601982]) double-knockout mice accumulate, with age,
higher levels of formamidopyrimidine DNA-glycosylase
(FPG)–sensitive sites—representing 8-oxoG lesions and
abasic sites—in hepatocytes, splenocytes, and kidney
cells than ogg1/ mice, which indicates an influence of
CSB on accumulation of endogenous oxidative damage
(Osterod et al. 2002).
CSB-Influenced Processes
Venema et al. (1990) first showed that CS cells have a
defect in TCR of UV-induced DNA damage (Venema et
al. 1990); later, the hamster gene ercc6 (MIM 133540),
encoding the homologue of human CSB, was cloned on
the basis of its ability to complement the TCR defect
(Troelstra et al. 1992). Using a nucleotide resolution ap-
proach, Tu et al. (1997) showed that CSB-deficient cells
have a defect in repair of the transcribed strand of the
JUN gene (MIM 165160) downstream from 20—a
fast repair around the transcription initiation site—and
a reduced repair of the promoter region (Tu et al. 1997).
TCR is thought to remove transcription-blocking le-
sions in actively transcribed genes, possibly by a re-
cruitment of repair factors to the DNA lesion after re-
moval of the stalled RNA polymerase (Svejstrup 2002).
On the basis of the lack of recovery of RNA synthesis
in CSB cells after 4-NQO and NA-AAF treatment, in
spite of the inflicted lesions being repaired by GGR, an
alternative model has been proposed. In this model, CSB
acts as a transcription-repair-uncoupling factor, possibly
by helping TFIIH switch from a repair to a transcription
mode. However, a recent study by Hoogstraten et al.
(2002) showed that TFIIH moves freely and rapidly be-
tween transcription and repair in vivo (Hoogstraten et
al. 2002). Also, UV-induced transcription inhibition is
reported not to correlate with any lack of TFIIH in
nuclear extracts (Rockx et al. 2000).
The importance of preferential repair of actively ex-
pressed genes is suggested by the conservation of the
TCR pathway from Escherichia coli and yeast to man
(van Gool et al. 1997b). In E. coli, the transcription-
repair coupling factor (TRCF) that is known as “the Mfd
protein” can dissociate transcription complexes blocked
by DNA lesions and can recruit DNA repair proteins.
In Saccaromyces cerevisiae, TCR is divided into two
subpathways mediated by either the CSB homologue
Rad26 or the RNA Pol II subunit Rpb9 and is inter-
regulated by Rpb4 (Li and Smerdon 2002). Results sug-
gesting a role of TCR in the repair of thymine glycol
(TG) and 8-oxoG have been published (Leadon and
Cooper 1993; Cooper et al. 1997; Le Page et al. 2000),
but there are some concerns over the validity of these
results, since a number of these articles have been re-
tracted (Gowen et al. 2003). TCR and strand-specific
repair were not observed in the repair of 8-oxoG lesions
in endogenous genes of CHO cells (Thorslund et al.
2002). TCR of UV-induced lesions was initially observed
in endogenous genes, and, if TCR of 8-oxoG lesions
cannot be detected in endogenous genes in a similar
setting, it may suggest that 8-oxoG is repaired without
TCR. Whereas UV lesions are known to block tran-
scription, it is uncertain whether TG and 8-oxoG lesions
do the same (Le Page et al. 2000; Spivak et al. 2003).
Thus, if transcription arrest is a signal for TCR, this
signal may not exist in the repair of 8-oxoG. In addition
to CSB, several proteins appear to be involved in TC-
NER: CSA, RNA Pol II, XPA-binding protein 2 (XAB2),
and NER proteins (Henning et al. 1995; Nakatsu et al.
2000; Svejstrup 2002). Controversy exists as to a pos-
sible role of the mismatch-repair proteins hMSH2 (MIM
120435) and hMLH1 (MIM 120436) in TC-NER (Mel-
lon et al. 1996; Rochette et al. 2002; Leadon and Avrut-
skaya 2003).
As mentioned above, a characteristic of CSB cells is
the reduced general RNA synthesis. The effect on tran-
scription has been measured using methods specifically
detecting elongation, and CSB is suggested to function
as an elongation factor for RNA Pol II on undamaged
DNA (Balajee et al. 1997; Selby and Sancar 1997a;
Tantin et al. 1997). CSB has been shown (i) to promote
RNA Pol II transcription past natural pause sites in vitro
(Selby and Sancar 1997a; Tantin et al. 1997); (ii) to pro-
mote transcription of genes encoding highly structured
RNAs, such as the U1 (MIM 180680) and U2 (MIM
180690) small nuclear RNAs and 5S rRNA [MIM
180420] (Yu et al. 2000); and (iii) to stimulate rRNA
synthesis in vitro and in vivo (Bradsher et al. 2002).
This implicates CSB in transcription by RNA Pol I and
II and, indirectly through the effect on 5S genes, also
in RNA Pol III transcription. It is paradoxical that CSB
counteracts transcript shortening by elongation factor
TFIIS (MIM 601425) (Selby and Sancar 1997b), which
normally is a step in rescuing backtracked, arrested
elongation complexes. Perhaps the action of TFIIS and
CSB in promoting elongation is somewhat redundant.
The Mfd protein of E. coli has recently been found to
rescue arrested transcription complexes from their typ-
ical backtracked position, possibly by rewinding DNA
upstream of the complex and thereby pushing the com-
plex forward (Park et al. 2002).
UV—or cisplatin—treatment, which induces Pol II–
blocking lesions that are removed by TCR, also induces
ubiquitination of RNA Pol II in normal fibroblasts but
not in CSA or CSB fibroblasts (Bregman et al. 1996).
The ubiquitinated Pol II is in a hyperphosphorylated
state (Ratner et al. 1998). The C-terminal domain (CTD)
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of the Pol II large subunit changes phosphorylation state
during different stages of transcription, going from a
hypophosphorylated state, Pol IIa, at promoter binding
and transcription initiation to a hyperphosphorylated
state, Pol IIo, upon promoter escape and elongation.
The implication of CSB in the ubiquitination of Pol II
is supported by the preferential interaction of CSB with
elongating or stalled RNA Pol II (Tantin et al. 1997).
After UV-induced ubiquitination of the Pol II large sub-
unit, the level of this polypeptide is reduced. This re-
duction is inhibited by proteasome inhibitors, indicating
that ubiquitination targets the large subunit for protea-
somal degradation (Ratner et al. 1998). The reduction
in the Pol II large subunit level after UV treatment is
not seen in CSA or CSB cells (McKay et al. 2001). Also,
a correlation between ubiquitination and blockage of
transcription in vitro by a-amanitin has been found (Lee
et al. 2002a). Together, these results have led to a model
in which an elongating RNA Pol IIo that is stalled by
a CPD or cisplatin adduct can be ubiquitinated and
proteasomally degraded; this is somehow affected by
CSA and CSB (Svejstrup 2003). This proteasome-medi-
ated degradation is independent of p53 and appears im-
portant for recovery of RNA synthesis but not for TCR
(McKay et al. 2001).
By analogy to the Mfd protein of E. coli, CSB has
been suggested to directly dissociate stalled RNA Pol II.
However, using recombinant CSB in an in vitro tran-
scription assay, Selby and Sancar (1997b) found that
CSB could not dissociate the ternary complex of DNA,
mRNA, and stalled RNA Pol IIo (Selby and Sancar
1997b). This discrepancy has been proposed to be a
result of differences between prokaryotes and eukary-
otes in average transcript length, leading to a difference
in propensity to abort an incomplete transcript due to
DNA lesions. Eukaryotes might invest more resources
in DNA repair and resumption of transcription when
confronted with RNA Pol II blocks than do prokary-
otes. It could also be an artifact of the in vitro system
or the fact that recombinant-purified CSB is used (Svej-
strup 2003). However, another factor, human transcrip-
tion release factor 2 (HuF2), has been shown to dis-
sociate RNA Pol I and II stalled at CPDs in vitro (Hara
et al. 1999). This dissociation was not affected by ad-
dition of recombinant CSB (Hara et al. 1999). This
observation suggests some functional similarity between
HuF2 and TRCF and makes the incorporation of a
rapid dissociation activity of stalled RNA polymerases
important in models describing the effect of CSB on
stalled RNA Pol II in TCR in humans (Hara et al. 1999).
CSB has also been suggested to remodel the DNA-Pol
II interface to allow DNA repair or to promote bypass
of some types of damage (Svejstrup 2003). This has been
suggested from the findings that (i) the Mfd protein is
an ATP-dependent DNA translocase that can move ar-
rested RNA polymerase forward (Park et al. 2002), (ii)
the CSB-related RSC enzyme from the SNF2-like family
is a DNA translocase, and (iii) CSB can make a damage-
stalled Pol II add an extra nucleotide (Selby and Sancar
1997a; Svejstrup 2003).
The yeast homologue of CSB, Rad26, is found in a
complex with a factor called “Def1” (Woudstra et al.
2002). Rad26 protects RNA Pol II from degradation after
DNA damage, whereas Def1 is necessary for ubiquitin-
mediated degradation of stalled RNA Pol II (Woudstra
et al. 2002). These factors apparently exert opposing ef-
fects on the choice between repair and transcript abortion
after DNA damage in yeast. A recent hypothesis proposes
the existence of a similar complex in human cells with
CSB and an as-yet-unknown Def1-like factor (Svejstrup
2003). CSB could promote either translesion transcrip-
tion or ubiquitin-mediated degradation of RNA poly-
merase followed by NER, depending on the cause of
polymerase stalling. If neither approach is successful, an-
other activity, such as HuF2, could provoke removal of
RNA Pol II by dissociation, thereby preventing apoptosis.
As a member of the SNF2-like family, CSB is related
to the human Brg1 (MIM 603254), hBrm (MIM
600014), and the Drosophila ISWI, which are all ca-
pable of chromatin remodeling. This activity is impli-
cated in changing the structure of chromatin during
transcription regulation and was suggested to be relevant
in DNA repair as well (Citterio et al. 2000). The chro-
matin remodeling activity of CSB has been investigated
in vitro, and CSB was shown to remodel mononucleo-
somes and the chromatin structure on a chromatinized
plasmid (Citterio et al. 2000). This was not accom-
plished through complete dissociation of the histone oc-
tamer from DNA nor by octamer transfer from the mon-
onucleosome to free DNA; however, CSB was found to
interact with core histones through their N-terminal
tails and to induce negative supercoiling in a naked
singly nicked plasmid (Citterio et al. 2000). In support
of these results, a study of S. cerevisiae found, on de-
letion of rad26, the expression of genes normally re-
pressed by transposon d elements (Gregory and Sweder
2001). These d elements are thought to repress expres-
sion of certain genes by affecting local chromatin struc-
ture, and the result of the study therefore could impli-
cate Rad26 in chromatin remodeling (Gregory and
Sweder 2001).
Preferential repair of DNA associated with the nu-
clear matrix after UV irradiation (Mullenders et al. 1988)
and recruitment of different factors to the nuclear ma-
trix after UV irradiation is inhibited in CSB fibroblasts.
After UV irradiation, the proliferating cell nuclear an-
tigen (PCNA [MIM 176740]) forms an insoluble com-
plex with nuclear substructures in nondividing cells. This
occurs at a rate that is twofold lower in UV61 cells than
in normal hamster cells, and this defect can be rescued
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by transfection with the WT human CSB gene (Balajee
et al. 1998). PCNA can form a trimeric sliding clamp,
which is loaded onto DNA by replication factor C
(MIM 102579) and is involved in replication by poly-
merases d and  in NER resynthesis, long-patch BER,
postreplication repair, and mismatch repair. Balajee et
al. (1999) also investigated the induction of the PCNA
complex in human cells in response to UV and H2O2
(Balajee et al. 1999). They found a ninefold induction
of PCNA complex in normal cells after UV irradiation,
compared with fourfold induction in CSB fibroblasts
and close to none in XP-A cells, which corroborates the
data obtained with hamster cells (Balajee et al. 1999).
H2O2-induced oxidative damage gave an increase in
PCNA, in the detergent-insoluble fraction, of fivefold
in WT cells (Balajee et al. 1999). The induction was
1.7-fold lower in CSB cells (Balajee et al. 1999). Another
factor with a CSB-affected translocation to the nuclear
matrix after DNA damage is CSA (Kamiuchi et al. 2002).
Translocation of CSA is CSB-dependent; is induced by
UV irradiation, cisplatin, and H2O2 treatment; and re-
sults in colocalization of CSA with RNA Pol IIo (Ka-
miuchi et al. 2002). It is not induced by dimethyl sulfate
and is independent of XPA and XPC, which indicates
the TCR-specific nature of the response (Kamiuchi et
al. 2002). However, that study found that most of the
CSB was not present in the nuclear matrix fraction after
damage (Kamiuchi et al. 2002). Thus, the role of CSB
in the nuclear matrix is not yet understood. However,
it could be related to the chromatin-remodeling activity
of CSB.
The reduced PCNA complex formation in CSB cells
after H2O2 treatment indicates a defect in the response
to oxidative damage (Balajee et al. 1999). Dianov et al.
(1999) made the first demonstration of a global ge-
nome–DNA repair defect in CS cells, showing that the
incision of an 8-oxoG–containing oligonucleotide was
40%–50% reduced in whole-cell extracts from CS1AN
and primary CSB fibroblasts compared with normal cells
(Dianov et al. 1999). The 8-oxoG incision could be in-
creased 60% in CSB-deficient cells by transfection with
the CSB gene (Dianov et al. 1999). This in vitro incision
activity is thought to reflect global genome BER (GG-
BER), since the oligonucleotide is not transcribed and
is unlikely to have chromatin structure (Tuo et al. 2001).
UV61 transfectants without the CSB gene have 40% of
the 8-oxoG incision in whole-cell extracts, compared
with cells carrying a WT CSB gene copy (Sunesen et al.
2002). Using transfectants of CS1AN.S3.G2, Tuo et al.
(2001) also found a reduction in 8-oxoG incision, in
whole-cell extracts of CSB-deficient cells, to 33% of
levels found in CSB-proficient transfectants (Tuo et al.
2001). This correlated with a reduced cellular resistance
to g irradiation (Tuo et al. 2001). Further support of a
role for CSB in the processing of 8-oxoG lesions comes
from the finding that antibody-mediated depletion of
CSB from whole-cell extracts leads to a 25% reduction
in 8-oxoG incision, which can be restored by the ad-
dition of recombinant CSB (Tuo et al. 2002a). Also, the
electrophoretic mobility-shift assay (EMSA) protein-
binding capacity to an 8-oxoG–containing oligonucleo-
tide seen in whole-cell extracts from CSB-proficient cells
was abrogated in whole-cell extracts from cells lacking
CSB (Tuo et al. 2002a).
Apart from the in vitro incision assay, repair of oxida-
tive damage has also been measured in vivo by the re-
moval of FPG-sensitive sites after damage induction
with light-activated photosensitizers, such as acridine
orange, methylene blue, and RO19-8022, primarily in-
troducing 8-oxoG. FPG comes from E. coli and excises
8-oxoG and formamidopyrimidine, followed by DNA
strand cleavage. Sunesen et al. (2002) showed that the
removal of FPG-sensitive sites in an active dihydrofolate
reductase (DHFR [MIM 126060]) gene is dependent on
a functional CSB gene in UV61 transfectants (Sunesen
et al. 2002). This dependence on CSB was also shown,
in human CS1AN cells, by Stevnsner et al. (2002), in a
study in which expression of WT CSB increased the
repair rate of FPG-sensitive sites (Stevnsner et al. 2002).
Generally, the 8-oxoG incision and removal of FPG-
sensitive sites have provided corroborating results. The
incision of 8-oxoG has also recently been investigated
in mitochondrial extracts from both CS1AN fibroblasts
and mouse csb/ liver cells (Stevnsner et al. 2002). Stevn-
sner et al. (2002) found a reduced activity in both mutant
extracts, compared with those from WT cells, which
indicates a role for CSB in mitochondrial repair of oxi-
dative damage (Stevnsner et al. 2002).
The influence of CSB on BER of other types of oxi-
dative damage has been investigated. CSB has not been
found to have any effect on the incision of a TG-con-
taining oligonucleotide in whole-cell extracts (Balajee et
al. 1999; Selzer et al. 2002) or in mitochondrial extracts
(Stevnsner et al. 2002). However, Tuo et al. (2002b)
have recently found a 30% reduction in incision activity
of 8-oxoA:T– and 8-oxoA:C–containing oligonucleo-
tides by whole-cell extracts from CSB-deficient human
fibroblasts, compared with WT cells (Tuo et al. 2002b).
A recent article by Jensen et al. (2003) reported that 8-
oxoA:C is incised in mitochondria by a splice-form of
the enzyme OGG1 (Jensen et al. 2003). OGG1 also
incises the lesion in the nucleus (Jensen et al. 2003) and
is known to be responsible for incision of the majority
of 8-oxoG:C in mammals. Human CSB-deficient cells
have been shown to contain a reduced level of OGG1
mRNA (Dianov et al. 1999; Tuo et al. 2002a) and pro-
tein (Tuo et al. 2002a) compared with WT cells. OGG1
exists in a nuclear and a mitochondrial (mtOGG1) iso-
form, and the mtOGG1 protein level is also significantly
reduced in whole-cell extracts and mitochondrial ex-
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Table 1
Proteins Interacting or in Complex with CSB
Protein Factor Cellular Function References
CSA TCR Henning et al. 1995
XPB and XPD of TFIIH Transcription by Pol I and II, NER Selby and Sancar 1997b; Bradsher et al. 2002
XPG NER, stimulation of BER Iyer et al. 1996; Bradsher et al. 2002
XAB2 TCR Nakatsu et al. 2000
RNA Pol II Transcription Selby and Sancar 1997a; Tantin et al. 1997;
van Gool et al. 1997; Bradsher et al. 2002
RNA Pol I Transcription Bradsher et al. 2002
p44 and p62 of TFIIH Transcription by Pol I and II, NER Bradsher et al. 2002
p53 Cell cycle control, G1-arrest, NER, and apoptosis Wang et al. 1995; Yu et al. 2000
Histone 2A, 2B, 3, and 4 Chromatin component Citterio et al. 2000
p34 of TFIIE Transcription by RNA Pol II Selby and Sancar 1997b
OGG1 BER of 8-oxoG and 8-oxoA Tuo et al. 2002a
XPA NER Selby and Sancar 1997b
tracts from CSB-deficient human cells (Stevnsner et al.
2002). A direct physical and functional interaction be-
tween CSB and OGG1, however, has been difficult to
prove by use of purified components (see below), but
they are likely to be in the same protein complex (Tuo
et al. 2002a).
The general role of CSB in the removal of 8-oxoG
and 8-oxoA and the significance for the CS phenotype
is suggested by a recent study of primary fibroblasts from
11 patients with CS, 4 belonging to the CSB comple-
mentation group and 7 so far unassigned (Tuo et al.
2003). They all show a reduced incision activity com-
pared with WT whole-cell extracts (Tuo et al. 2003).
Proteins Interacting with CSB
Many proteins have been investigated for interactions
with CSB, often with contradicting results. These inter-
action studies are reviewed below; the positive interac-
tions are listed in table 1.
The CSA gene is mutated in patients with CS comple-
mentation group A (CSA). Henning et al. (1995) cloned
the gene in 1995 by complementation of the UV sen-
sitivity in CSA cells (Henning et al. 1995). The gene is
located at 5q12-q31 and encodes a protein of 46 kDa
with five WD40-repeats (Henning et al. 1995). Proteins
in the WD-repeat family are functionally diverse—with
roles in signal transduction, RNA processing, general
transcription, and cell division—but they have a high
structural similarity (reviewed by Smith et al. [1999]).
The only solved crystal structure is of the Gb subunit
of heterotrimeric G proteins. It has a barrellike shape
made up of repeating units of four-stranded b sheets.
CSA-deficient cells share many cellular characteristics
with CSB-deficient cells and have inhibited recovery of
RNA synthesis and TCR after UV irradiation (van Gool
et al. 1997a). CSA interacts with XAB2 (see below) in
vitro and in vivo (Nakatsu et al. 2000) and with the
p44 subunit (MIM 601748) of TFIIH in vitro (Henning
et al. 1995). A recent report has also shown an inter-
action with the N-terminal domain of topoisomerase I
by use of phage display (Trzcinska et al. 2002). CSA
has been found in a complex with DDB1 (MIM
600045), Cul4A (MIM 603137), Roc1 (MIM 603814),
and CSN (Groisman et al. 2003). This complex has
ubiquitin ligase activity, regulated in a UV-dependent
manner (Groisman et al. 2003). No interaction with
p62 (MIM 189972), XPD, XPB from TFIIH (Henning
et al. 1995), or XPG (van Gool et al. 1997a) has been
found.
Conflicting reports exist regarding a putative inter-
action between CSA and CSB. Henning et al. (1995)
found an interaction using coimmunoprecipitation (co-
IP) of in vitro translated proteins, and they reported a
corroborating result from a yeast two-hybrid study (Hen-
ning et al. 1995). However, no association has been
found using co-IP in whole-cell extracts, gel filtration,
or copurification (Tantin et al. 1997; van Gool et al.
1997a); CSB and CSA do not colocalize in nuclear ma-
trix preparations when immunofluorescence is used;
and CSB can be isolated in a large complex devoid of
CSA (Bradsher et al. 2002). Though implying the lack
of a strong direct interaction, these results do not rule
out the possibility of weak, transient, possibly damage-
induced interactions. As mentioned above, CSA is trans-
located to the nuclear matrix after damage in a CSB-
dependent manner, where it colocalizes with RNA Pol
IIo (Kamiuchi et al. 2002). Also, the CSA-containing
complex binds RNA Pol IIo after UV irradiation (Grois-
man et al. 2003).
The XPB gene, located at 2q21, encodes an 89-kDa
polypeptide. Mutations in this gene result in the XPB/
CS complex or in the transcription disorder trichothio-
dystrophy (TTD [MIM 601675]) (reviewed by de Boer
and Hoeijmakers [2000]). The XPB protein is a 3′–5′
helicase and one of nine subunits of TFIIH. XPB func-
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tions as a part of TFIIH in transcription initiation of RNA
Pol I and II and in the unwinding step of NER. Through
use of a green fluorescent protein tag, XPB has recently
been shown to be homogeneously distributed through-
out the nucleoplasm, with particular enrichment in nu-
cleoli (Hoogstraten et al. 2002). The nucleolar locali-
zation was abrogated by UV irradiation. XPB interacts
with the TFIIH subunits XPD, p62, p44, and p34, as
well as with XPG (Iyer et al. 1996). XPB and CSB have
been shown to interact by use of a pull-down with CSB-
GST fusion protein (Selby and Sancar 1997b). An in-
teraction is also indicated by the ability of an XPB-
containing factor to supershift a complex of elongating
RNA Pol II:DNA:RNA:CSB only when it contains CSB
(Tantin 1998). However, Gool et al. (1997a) found XPB
and CSB fractionating differently on chromatography
and saw no co-IP of the two (van Gool et al. 1997a).
Contrary to this, a recent study reports XPB colocalizing
with CSB and RNA Pol I in nuclear matrix preparations
and identifies XPB in a CSB-containing complex im-
munoprecipitated at physiological salt concentration
(Bradsher et al. 2002).
XPD is a helicase like XPB but with the opposite di-
rectionality, going 5′r3′. It is also a subunit of TFIIH and
participates in the same processes as mentioned above
for XPB. The gene is located at 19q13.2-q13.3 and, when
mutated, gives rise to one of three disorders: XP, TTD,
or XPD/CS. Like XPB, it interacts with some of the
other subunits of TFIIH, namely p62, p44, and p34
(Iyer et al. 1996). It can be coimmunopurified with XPG
in vitro (Iyer et al. 1996). XPD has been reported not
to copurify with CSB (van Gool et al. 1997a). However,
XPD can be found in the same large CSB-containing
complex described for XPB (Bradsher et al. 2002). This
complex could replace TFIIH in transcription and in-
cision assays in vitro. It was suggested that mutations
in XPB and XPD, which both can result in a partial CS
phenotype, could destabilize this complex and thereby
affect the function of CSB (Bradsher et al. 2002).
XPG is the third gene in which mutations can give
rise to an XP/CS phenotype (reviewed by de Boer and
Hoeijmakers [2000]). It is located at 13q33 and encodes
a DNA endonuclease responsible for the incision 3′ to
the DNA lesion in NER. XPG mutations leading to
XPG/CS have, in all reported cases, resulted in severely
truncated proteins (Nouspikel et al. 1997), whereas pa-
tient XP125LO with XPG has a full-length protein with
a mutation that abolishes its endonuclease activity.
Klungland et al. (1999) found that XPG can stimulate
the incision activity of the DNA glycosylase Nth1 (MIM
602656) involved in BER of oxidative damage in vitro
(Klungland et al. 1999). This effect is intact with a full-
length mutant XPG lacking endonuclease activity, in-
dicating that the XPG stimulation of BER is intact in
patients with XPG (Klungland et al. 1999). The authors
suggest that a full-length XPG is necessary for this func-
tion and that this contributes to the difference in the
XPG and XPG/CS phenotypes. Interactions between
XPG and XPB, XPD, p62, and p44 have been demon-
strated (Iyer et al. 1996). XPG has been shown to interact
with CSB through use of in vitro co-IP (Iyer et al. 1996),
but they do not copurify or coimmunoprecipitate from
HeLa whole-cell extracts (van Gool et al. 1997a). How-
ever, XPG participates in a large CSB-containing com-
plex (Bradsher et al. 2002). Large truncating mutations
in XPG, as seen in patients with XPG/CS, could poten-
tially destabilize this complex, as suggested for XPB and
XPD.
XPA is involved in the early steps of NER, but its
exact role is not yet clear (Reardon and Sancar 2002).
It is thought to help recognize the damaged DNA and
to be necessary for both GG-NER and TC-NER (re-
viewed by de Boer and Hoeijmakers [2000]). XPA in-
teracts with other NER proteins, including TFIIH, XPF/
ERCC1, and RPA. Used as bait in a yeast two-hybrid
screen, XPA was found to interact with a previously
unknown protein, XAB2 (see below) (Nakatsu et al.
2000). An interaction between CSB and XPA could the-
oretically provide the link between TCR and a classical,
early NER factor. However, this has been tested by two
different methods, with contradicting results (Selby and
Sancar 1997b; van Gool et al. 1997a).
XAB2 is a tetratricopeptide repeat protein homolo-
gous to SYF1 from S. cerevisiae and to predicted ORFs
from several other organisms (Nakatsu et al. 2000). The
functions of the homologous proteins are unknown, but
XAB2 is apparently involved in TCR and transcription.
Microinjection of anti-XAB2 antisera into WT and XP-
C fibroblasts resulted in reduction in recovery of RNA
synthesis after UV irradiation, in unscheduled DNA re-
pair synthesis after UV irradiation, and in reduction in
normal transcription (Nakatsu et al. 2000). XAB2 in-
teracts with XPA, CSA, and a fraction of RNA Pol II
(Nakatsu et al. 2000). XAB2 can be immunoprecipi-
tated from whole-cell extracts of CSB cells with a stable
expression of HA-His6–double-tagged CSB by use of anti-
HA antibody, and it cofractionates with CSB and RNA
Pol II (Nakatsu et al. 2000). Tetratricopeptide repeat
motifs are arranged into a right-handed superhelix and
are proposed to simultaneously interact with many pro-
teins. XAB2 could serve as a bridging protein among
the transcription, TCR, and the NER machinery (Nak-
atsu et al. 2000).
As suggested by its role in transcription and TCR,
CSB has been found to interact with RNA Pol II in vitro
and to reside in a common, large complex (Selby and
Sancar 1997a; van Gool et al. 1997a; Bradsher et al.
2002). CSB interacts with both Pol IIa and IIo, with a
preference for Pol IIo (Selby and Sancar 1997a; Tantin
et al. 1997). As mentioned above, CSB has also been
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Figure 2 Predicted motifs of CSB. A p acidic domain. G p glycine-rich stretch. H p hydrophilic region. N p bipartite NLS. I–VI p
ATPase motifs located in the SNF2 domain conserved among the members of the SNF2-like family. NTB p putative NTB motif.
implicated in transcription by RNA Pol I and was found
to reside in a complex with RPA116 (from RNA Pol I)
and TAF68 (TIF-1B) but lacking RPB1 (RNA Pol II)
and TAFII 250 (MIM 313650) (Bradsher et al. 2002).
Explaining this discrepancy, CSB was in complex with
RNA Pol I when purified using 150 mM KCl but with
RNA Pol II when using 50 mM KCl (Bradsher et al.
2002). It is possible that the salt concentration–depen-
dent variation of CSB-complex association reflects the
difference in osmotic concentration between the nucle-
olus and the regions of RNA Pol II transcription. The
effect of CSB on the metaphase stability of the 5S rRNA
locus indicates a role in RNA Pol III transcription and
the possibility of a direct interaction (Yu et al. 2000).
The CSB-containing complex isolated at physiologi-
cal salt conditions also contains the p44 and p62 sub-
units of TFIIH (Bradsher et al. 2002). Both of these
interact with XPB, XPD, and XPG (Iyer et al. 1996),
whereas only p44 interacts with CSA (Henning et al.
1995). CSB has been reported to interact with the p34
subunit of TFIIE (MIM 189962) (Selby and Sancar
1997b), the tumor suppressor protein p53 (Wang et al.
1995; Yu et al. 2000), and the N-terminal tail of core
histones (Citterio et al. 2000). Recently, p53 was reported
to be a chromatin-accessibility factor for GG-NER
(Rubbi and Milner 2003). The chromatin relaxation is
probably initiated by the blocking of a transcribing
RNA polymerase but is independent of TCR and CSB
function. A CSB interaction with OGG1 not mediated
by DNA was found using a pull-down from whole-cell
extracts (Tuo et al. 2002a). However, this could not be
confirmed by a yeast two-hybrid assay or by EMSA
super shift, indicating other factors might mediate the
interaction (Tuo et al. 2002a).
Several proteins have been tested for an interaction
with CSB, with negative results. These include p56 of
TFIIE, TFIIF, RPA, XPC/hHR23B, and XPF/ERCC1
(Selby and Sancar 1997b; van Gool et al. 1997a). In
summary, CSB interacts physically with CSA, RNA Pol
II, XAB2, histones, TFIIE, and p53 and can exist in
complex with XPA, XPB, XPD, XPG, RNA Pol I, the
TFIIH subunits p44 and p62, and possibly OGG1.
These relations are listed in table 1. However, many of
the protein interactions described here are observations
of CSB binding to other proteins and, although these
physical interactions are of interest, it is important to
search for functional interactions.
Biochemical Characteristics of CSB
In 1992, the human homologue of the hamster ercc6 gene
was cloned by Troelstra et al. (1992). Because of alter-
native polyadenylation, the expression of ercc6 results in
two mRNAs, of 5 kb and 7.5 kb. The longest ORF en-
codes a predicted protein sequence of 1,493 amino acids,
which, through complementation studies, was found to
be the protein responsible for the phenotype of CS. CSB
has a molecular weight of 168 kDa and contains several
conserved motifs (Troelstra et al. 1992) (fig. 2). Among
these are the seven consecutive ATPase motifs I, Ia, II,
III, IV, V, and VI from amino acids 527–950. These
motifs form a nucleotide-binding fold and are conserved
among three superfamilies of RNA and DNA helicases,
which places CSB in superfamily 2. The region of CSB
encompassing these motifs is highly homologous to pro-
teins of the SNF2-like family, such as SWI2/SNF2 (MIM
600014), Sth1, hBrm, BRG1, ISWI, MOT1 (or TAF-172
[MIM 605191]), SRCAP, RAD54 (MIM 603615),
RAD16, RAD5 (MIM 607266), and HuF2 (fig. 3). Thus,
CSB is placed in the ERCC6 subfamily of the SNF2-like
family, together with its yeast homologue Rad26 (re-
viewed by Pazin and Kadonaga [1997]).
As shown in figure 2, CSB has an acidic region ex-
tending N-terminal to the ATPase motifs from amino
acids 356–394, encompassing 60% acidic residues and
an acidic stretch of 10 consecutive amino acids (Troel-
stra et al. 1992). Between these two motifs is a glycine-
rich stretch of seven residues and a highly hydrophilic
region with 160% charged amino acids. C-terminal to
the ATPase motifs is a second putative nucleotide-bind-
ing (NTB) domain. The protein contains a bipartite nu-
clear-localization signal (NLS) with two predicted casein
kinase II (CKII [MIM 115440]) phosphorylation sites
nearby (Troelstra et al. 1992). Christiansen et al. (2003)
recently reported that CSB contains several additional
putative CKII sites, multiple phosphorylation sites for
protein kinase C, and two sites recognizable by tyrosine
kinases (Christiansen et al. 2003).
Owing to its relatedness to RNA and DNA helicases,
CSB has been tested for DNA-helicase activity. When a
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Figure 3 Selected members of the SNF2-like family. Examples of family members from S. cerevisiae, Drosophila melanogaster, and humans
(Homo sapiens) are listed. Conserved regions and functionally important motifs are indicated.
strand-displacement assay was used in vitro, no helicase
activity was found, nor did the addition of CSA to the
reaction have any effect (Selby and Sancar 1997b).
In corroboration of this, a later study found no CSB-
helicase activity on a variety of different DNA substrates
(Citterio et al. 1998). Indeed, no member of the SNF2-
like family has thus far exhibited helicase activity (Pazin
and Kadonaga 1997). It remains to be established
whether the lack of measurable helicase activity could
be due to the absence of a crucial accessory protein
or cofactor. However, CSB exhibits DNA-dependent
ATPase activity (Selby and Sancar 1997b; Citterio et al.
1998; Christiansen et al. 2003). It is highly stimulated
by the presence of DNA, with a markedly larger effect
of dsDNA than ssDNA (Tantin et al. 1997; Citterio et
al. 1998; Christiansen et al. 2003). Comparing the ef-
fects of different dsDNA structures, Christiansen et al.
(2003) recently found a 60% increase in ATPase activity
when using dsDNA cofactors with a bubble or loop
(corresponding to the open DNA structure during NER
and transcription arrest), compared with using closed
dsDNA (Christiansen et al. 2003). A dsDNA with a
larger bubble, corresponding to what is found during
transcription elongation, had no additional effect, com-
pared with closed dsDNA, nor did loose structures with
dsDNA-to-ssDNA transitions (Christiansen et al. 2003).
These data corroborate the role for CSB in coupling NER
to arrested transcription complexes in TCR. Damaged
DNA used as cofactor did not result in any significant
change in the ATPase activity of CSB (Christiansen et al.
2003), indicating that CSB is not a damage-recognition
factor on its own. The presence of XPA or p53 did not
affect the ATP hydrolysis (Christiansen et al. 2003);
however, the addition of CSA to CSB and dsDNA was
reported by Tantin et al. (1997) to increase the ATPase
activity. Data on the effect of the various DNA cofactors
are all in vitro results, through use of naked DNA. How-
ever, there is no detectable difference in the stimulatory
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effect of naked versus chromatinized DNA (Citterio et
al. 1998).
CSB is capable of binding dsDNA in vitro in the ab-
sence of ATP and the nonhydrolyzable ATPgS (Tantin
et al. 1997). DNA binding is actually inhibited in the
presence of ATPgS and ADP (Christiansen et al. 2003).
Thus, it is not necessary for CSB to bind ATP in order
to bind DNA, but DNA binding is stimulated by certain
protein conformations. These conformations are prob-
ably compatible with binding and hydrolyzing ATP but
not with binding the structurally different and nonhy-
drolyzable ATPgS or the hydrolysis end-product ADP.
Through use of immunofluorescence and CS1AN
.S3.G2 cells stably transfected with enhanced cyano-
fluorescent protein–tagged CSB, CSB localizes to nuclei
(van Gool et al. 1997a; Christiansen et al. 2003). This
is in agreement with the prediction of a bipartite nu-
clear-localization signal in the amino acid sequence of
CSB. During metaphase, CSB colocalizes with micro-
tubuli of the mitotic spindle rather than with chromatin
(van Gool et al. 1997a). Recently, it has been found that
TCR is localized to specific chromosomal domains cor-
responding to the distribution of the human transcrip-
tome, CpG islands, and regions of hyperacetylated his-
tones (Surralles et al. 2002). This suggests that CSB
might also be concentrated in certain subnuclear regions.
Indeed, Bradsher et al. (2002) have recently reported
that CSB localizes to nucleoplasmic foci and accumu-
lates in nucleoli of normal human fibroblasts (Bradsher
et al. 2002). In nuclear matrix preparations, CSB is
detected in the nucleolus together with RNA Pol I and
the XPB subunit of TFIIH (Bradsher et al. 2002). The
localization of CSB is dynamically dependent on the RNA
polymerase activity: when RNA Pol II is inhibited, the
nucleoplasmic CSB signal weakens and, on treatment
with actinomycin D, CSB is dispersed from nucleoli
(Bradsher et al. 2002). Unlike what has been reported
for CSA, no relocalization of CSB after UV irradiation
was reported by van Gool et al. (1997a).
CSB has not been reported to localize to mitochon-
dria, and no mitochondrial target sequences have been
identified in the protein sequence. However, these sig-
nals are variable and not always easily recognizable,
and CSB may be present in levels below the present
detection limit. The effect of CSB on GG-BER– and
OGG1-mediated incision (see above) in mitochondrial
preparations naturally leads to the proposition of a frac-
tion of the CSB, perhaps the alternatively polyadeny-
lated form, localizing to the mitochondria, where these
processes also take place.
A recent study by Christiansen et al. (2003) shows
that CSB can be phosphorylated in vitro by CKII and
in whole-cell extracts from human fibroblasts (Chris-
tiansen et al. 2003). CSB is also phosphorylated in vivo;
this can be reversed by UV irradiation (Christiansen et
al. 2003). This indicates a phosphorylation-dependent
regulation of CSB activity after DNA damage, corrob-
orated by the finding that dephosphorylation of CSB by
protein phosphatase 1 (MIM 176875) increases the
ATPase activity by 38% (Christiansen et al. 2003). So
far, no other type of posttranslational modification has
been reported for CSB. However, the recent discovery
associating CSA with ubiquitin-ligase activity prompts
speculations as to the role of ubiquitin in TCR. A general
role for ubiquitin and the related SUMO proteins in the
regulation of DNA repair is emerging with their differ-
ential effect on PCNA in postreplicative repair (Pickart
2002).
Structure-Function Relationships
Several functional studies have been conducted using
various CSB mutants. The emerging structure-function
relationships are discussed below and are summarized in
table 2.
Of the seven ATPase motifs, motifs I and II have also
been called “Walker A” and “Walker B,” respectively,
because they contain consensus sequences originally
found by Walker in a family of NTP-binding proteins.
They are therefore thought to be involved in ATP bind-
ing by CSB and in CSB-mediated hydrolysis (Hall and
Matson 1999). Mutant proteins with point mutations
of highly conserved residues in motifs I and II are devoid
of ATPase activity in vitro (Citterio et al. 1998; Chris-
tiansen et al. 2003). Mutation of motif I and the re-
sulting lack of ATPase activity leads to a partial defect
in recovery of RNA synthesis after UV treatment, in-
dicating an inhibition of TCR (Citterio et al. 1998). A
functional motif I is also necessary for chromatin re-
modeling in vitro but not for the induction of topolog-
ical change in naked DNA (Citterio et al. 1998). Com-
parison with crystal structures of proteins that belong
to SF1 and SF2 suggests an interaction between the
invariant lysine of the signature amino acid sequence
GSGKS Walker A of motif I and the ATP b-phosphate.
It is possible that this helps stabilize the transition state
during hydrolysis (Hall and Matson 1999).
Several functional studies have been conducted using
the E646Q CSB motif II mutant. The altered glutamate
is a part of the conserved amino acid sequence DEXH
involved in Mg2 binding and necessary for ATP hy-
drolysis (Hall and Matson 1999). The CSB E646Q mu-
tant cannot complement the UV sensitivity, the inhibited
recovery of RNA synthesis after UV treatment, or the
increased UV-induced apoptosis of UV61 and CS1AN
.S3.G2 cells (Brosh et al. 1999; Balajee et al. 2000; Selzer
et al. 2002). Thus, it appears defective in TCR of UV-
induced damage. This is corroborated by a defect in
gene-specific repair of CPDs in the DHFR gene of
E646Q-transfected UV61 cells (Brosh et al. 1999). This
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Table 2
Structure-Function Relationships of CSB
FUNCTION ACIDIC
MOTIF
NTBI IA II III IV V VI
ATPase activity ND  ND  ND ND   ND
ATP binding ND ND ND  ND ND   ND
DNA binding ND ND ND  ND ND   ND
Gene-specific repair  ND ND  ND ND ND ND ND
Chromatin remodeling ND  ND ND ND ND ND ND ND
8-oxoG incision  ND    ND  () 
8-oxoA incision ND ND ND ND ND ND ND  ND
hOGG1 expression ND ND ND  ND ND ND  ND
RRSa after UV irradiation ND    () ND   
RRSa after 4-NQO ND ND ND  ND ND ND ND ND
UV-induced apoptosis  ND ()  () ND   
UV sensitivity  ND ()  () ND   
4-NQO sensitivity ND ND    ND   ()
8-oxoG accumulation ND ND ND ND ND ND ND  ND
8-oxoA accumulation ND ND ND ND ND ND ND  ND
g-radiation sensitivity ND ND  ND  ND   
NOTE.—Selected functional characteristics of the CSB protein carrying mutations in various protein motifs.
Levels of function:  p better than WT;  p WT;  p weak deficiency; p strong deficiency;
p complete deficiency. NDp no data. Plus signs () in parentheses indicate a level of function intermediate
between the level indicated by the total number of plus signs for a given function and the level below.
a RRS p recovery of RNA synthesis.
mutant was also unable to complement the sensitivity
toward and the defect in recovery of RNA synthesis
after 4-NQO (Brosh et al. 1999). Since 4-NQO–induced
damage is repaired by GGR, this indicates that the mu-
tant is defective in reactivation of RNA synthesis after
damage, possibly owing to a lack of reactivation of
RNA polymerases. The role of motif II and the ATPase
activity in the processing of oxidative damage has also
been investigated. Sunesen et al. (2002) reported a re-
duced 8-oxoG incision in whole-cell extracts from UV61
cells transfected with CSB E646Q, compared with WT
transfectants (Sunesen et al. 2002). Also, the rate of
removal of FPG-sensitive sites in the DHFR gene was
reduced in the mutant transfectants (Sunesen et al.
2002). However, Selzer et al. (2002) did not see any
effect of E646Q on H2O2 sensitivity or 8-oxoG incision
in transfected CS1AN.S3.G2 cells (Selzer et al. 2002).
Stevnsner et al. (2002) have recently investigated the
role of motif II in mitochondrial repair of oxidative
damage in human cells. The integrity of this motif and
the ATPase activity has no influence on the repair of 8-
oxoG in vitro and in vivo, nor does it affect the level
of mtOGG1 protein (Stevnsner et al. 2002). In a recent
study, Kyng et al. (2003), using CS1AN.S3.G2 fibro-
blasts, reported a transcriptional response of the E646Q
mutant after exposure to H2O2, that corresponds to
what is seen for a CSB-null mutant, with a reduced,
delayed induction of the response and changed expres-
sion of 122 genes, compared with what is seen for the
WT (Kyng et al. 2003). Thus, this mutation might have
an effect on the cellular response to oxidative damage,
and it seems to be primarily nuclear. Recently, Chris-
tiansen et al. (2003) did not find any change in DNA
binding of the CSB motif II mutant in vitro (Christian-
sen et al. 2003). This confirms the primary involvement
of motif II in ATP binding and hydrolysis and not in
nucleic-acid binding.
Studies of CSB-deficient cells transfected with CSB mu-
tant proteins with point mutations in either ATPase motif
Ia or III have revealed almost identical phenotypes, sug-
gesting a common functional role for these motifs. Both
motifs can only partially complement the increased sen-
sitivity toward UV and 4-NQO of CSB-deficient cells
(Tuo et al. 2001; Muftuoglu et al. 2002). This mal-
function is also reflected in a partial defect in the modu-
lation of UV-induced apoptosis and in a reduced recovery
of RNA synthesis after UV irradiation (Muftuoglu et al.
2002). The CSB mutant deviates neither from the WT
level in sensitivity toward g irradiation nor in 8-oxoG
incision (Tuo et al. 2001), indicating that, whatever their
normal role is, the conservation of important residues
in motifs Ia and III is not important for the function of
CSB in GG-BER. Studies of homologous proteins sug-
gest the involvement of motifs Ia and III in energy trans-
duction between the ATPase site and the nucleic acid–
binding site (Hall and Matson 1999). However, future
studies of the ATPase activity and DNA-binding ca-
pacity of these mutants are necessary to further clarify
their exact role.
The ATPase motifs V and VI of CSB have also been
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studied using point mutations of invariant residues and
stable CS1AN transfectants. These mutants exhibit a
similar, almost complete, inhibition of ATPase activity
and reduced ATP binding in vitro (Christiansen et al.
2003). They are also equally sensitive to 4-NQO and UV
treatment and have comparable defects in recovery of
RNA synthesis and apoptosis induction after UV irra-
diation (Tuo et al. 2001; Muftuoglu et al. 2002). These
results indicate a necessary contribution of motifs V and
VI to TCR and RNA synthesis resumption, a role shared
by motif I and II mutants and thereby probably attrib-
utable to the common effect on ATPase activity. How-
ever, motif V and VI mutants show differences in their
response to oxidative damage. They both show in-
creased g irradiation sensitivity and reduced 8-oxoG
incision, but although these defects in motif VI mutants
are comparable to what is seen for CSB null mutants,
motif V mutants are at an intermediary level (Tuo et al.
2001). Further studies of the involvement of CSB motif
VI mutants in BER of oxidative damage have been con-
ducted by Tuo et al. (2001). CS1AN transfectants that
carry motif VI mutants accumulate 8-oxoG and 8-oxoA
in genomic DNA after g irradiation to the same extent
as does a CSB-null mutant (Tuo et al. 2001, 2002b).
Also, the mutants exhibit a twofold reduction in 8-
oxoA:C and 8-oxoA:T incision compared with WT (Tuo
et al. 2002b). These defects correlate with a reduction
in the cellular level of OGG1 transcript and protein (Tuo
et al. 2002a), suggesting a causative relationship be-
tween a failure to induce the expression of OGG1 and
an inhibited BER of 8-oxoG and 8-oxoA. The structure
of related proteins in the helicase superfamilies propose
that motif V binds ssDNA directly (Hall and Matson
1999). This has not been tested, but CSB motif V mu-
tants bind to dsDNA in vitro as efficiently as WT CSB
(Christiansen et al. 2003).
The effect of CSB motif VI mutants on DNA binding
is not detectable on dsDNA in vitro (Christiansen et al.
2003) but could possibly be evident on ssDNA, as sug-
gested for motif V. As mentioned above, the CSB ATPase
activity is stimulated to a much higher degree by dsDNA
than by ssDNA, apparently contradicting ssDNA bind-
ing by motif V and maybe VI. However, as mentioned
above, Christiansen et al. (2003) have recently found that
the stimulatory effect is even higher for dsDNA con-
taining a small bubble or loop, suggesting that some
parts of CSB contact dsDNA—whereas others contact
ssDNA—and placing CSB at the ssDNA-to-dsDNA
transition of the structure. A putative candidate for the
dsDNA binding is the as-yet-uninvestigated motif IV,
which, from the structure of the SF2 member NS3, is
known to contact the DNA backbone directly (Hall and
Matson 1999).
The members of the SNF2-like family are highly ho-
mologous over the entire region that contains the seven
ATPase motifs, named “the SNF2 domain” by Eisen et
al. (1995). Therefore, the motifs and structures giving
them their functional specificity are expected to lie out-
side this domain. In CSB, one of the most evident do-
mains outside the ATPase region is the acidic region.
Different types of acidic domain mutants have been es-
tablished and investigated (Brosh et al. 1999; Sunesen
et al. 2000). A mutant with a complete deletion of the
39 amino acids composing the acidic domain showed
full complementation of UV survival, gene-specific CPD
repair, UV-induced apoptosis propensity, PCNA reloca-
tion after UV irradiation, and NA-AAF survival of UV61
cells (Sunesen et al. 2000). A recent article from Sunesen
et al. (2002) further shows that the acidic domain is
superfluous in BER of oxidative damage in vivo and in
vitro in UV61 cells (Sunesen et al. 2002). Thus, so far,
no role has been assigned to the acidic domain. However,
all published studies on this domain have been performed
in UV61 cells, and the possibility for interspecies differ-
ences exists. Acidic domains in other proteins have been
implicated in transcriptional activation and in protein-
protein interactions, and an investigation of the tran-
scriptional response after oxidative stress in CSB acidic
domain deletion mutants could be interesting.
The putative NTB box C-terminal to the ATPase do-
main contains a Walker A GXGKT amino acid motif,
and a mutant with a substitution of the highly conserved
lysine CSBK1137Q has been established (Tuo et al.
2001). This mutant is phenotypically very close to WT
CSB in all parameters tested, including cellular sensi-
tivities, recovery of RNA synthesis, and 8-oxoG incision
(Tuo et al. 2001; Muftuoglu et al. 2002). Thus, no func-
tion has so far been assigned to this motif.
So far, there have been no reported structure-function
experiments involving the putative NLS sequences, the
glycine-rich stretch, the hydrophilic segment, or the ATP-
ase motif IV. It is most likely that the bipartite NLS signal
is necessary for the nuclear localization of CSB. This is
corroborated by the fact that mutations in other parts
of CSB—namely motifs II, V, and VI—did not affect the
localization of CSB (Christiansen et al. 2003). The gly-
cine-rich stretch could give this region of the protein a
high conformational flexibility and may be a flexible
joining of two major protein domains. This would sub-
divide CSB into an N-terminal third and a C-terminal
two-thirds. A subdivision with a flexible hinge domain
is reminiscent of what is seen in transcription factors,
with separate DNA-binding and transcription-activat-
ing or -repressing domains. It is interesting that no func-
tion has yet been assigned to any part of this N-terminal
third and that hardly any mutations in this part of the
gene have been found in the investigated patients with
CSB (Mallery et al. 1998). This can imply one of two
things: either this region is practically dispensable and
mutations located here do not lead to CS or any other
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overt phenotype, or mutations in this region lead to
severe inviable phenotypes and are therefore never pre-
sented in any patient.
The ATPase activity of motif Ia and III mutants has
not been assayed. However, it has been suggested that
these motifs mediate the internal energy transduction of
CSB between ATP hydrolysis and nucleic-acid binding.
Combining this with their defects in TCR-related pa-
rameters and WT response to oxidative damage suggests
that a separation of the ATPase activity and the DNA
binding inhibits TCR but not CSBs function in BER.
The interrelation between energy production and DNA
binding is likely to be necessary to mediate changes
in protein-DNA interactions. Thus, CSB might work
through fundamentally different mechanisms in medi-
ating its function in TCR and GG-BER. It is possible
that DNA binding and protein interactions are sufficient
for transcriptional activation and stimulation of various
factors involved in BER and factors induced by oxi-
dative stress. The role of motifs V and VI in BER could
be due to their effect on nucleic-acid binding and general
stabilization of the protein structure rather than caused
by the effect on ATP hydrolysis.
As mentioned above, the members of the SNF2-like
protein family share ATPase motifs located in the con-
served SNF2 domain. However, none of these proteins
exhibits helicase activity, unlike most of the other mem-
bers of SF1, SF2, and SF3. A function shared by several
of the SNF2-like family members is their ability to
modulate protein-DNA interactions in an ATP-depen-
dent manner (reviewed by Pazin and Kadonaga [1997]).
SWI2/SNF2, BRG1, hBrm, Sth1, and ISWI are the cata-
lytic subunits of different multiprotein complexes, which
all have the ability to modulate chromatin structure
when hydrolyzing ATP (Travers 1999). As reported for
CSB, these proteins are capable of catalyzing nucleo-
some remodeling in vitro without the presence of the
rest of their respective complex (Travers 1999; Citterio
et al. 2000). However, their modulating abilities are
changed when encompassed in different complexes, as
is exemplified by the different characteristics displayed
by the NURF, CHRAC (MIM 607268), and ACF com-
plexes, which all contain ISWI (Travers 1999). It is pos-
sible that the nucleosome-remodeling activity of CSB is
also modulated by different protein interactions as well
as by its incorporation into large complexes. Whereas
the nucleosome-remodeling activity of ISWI, hBrm,
BRG1, Sth1, and SWI2/SNF2 is implicated in changes
in gene expression, it has been suggested that the CSB-
mediated change in chromatin structure makes DNA
lesions accessible to repair (Citterio et al. 2000). The
ATP-dependent nature of nucleosome remodeling sug-
gests that the process is necessary for the function of CSB
in TCR but not for its role in BER of oxidative lesions.
Protein-DNA interactions are also affected by the family
members MOT1 and HuF2. These factors displace the
TATA box-binding protein (TBP [MIM 600075]) from
the TATA box and stalled RNA Pol I and II from CPD-
containing DNA, respectively (Auble and Steggerda
1999; Hara et al. 1999). It has been suggested by Cit-
terio et al. (2000) that CSB could use its ATPase activity
to weaken and change the interaction between stalled
RNA Pol II and DNA (Citterio et al. 2000). This could
allow repair of a polymerase-blocking lesion and/or re-
sumption of elongation.
Some SNF2-related proteins, such as MOT1 and Sth1,
have a general effect on transcription, whereas others
target specific genes or cofactors. SRCAP is a coactivator
for the CREB-binding protein (CBP [MIM 600140]) at
a subset of the CBP-influenced genes (Johnston et al.
1999), and the SWI/SNF complex targets and activates
specific genes through local nucleosome remodeling. CSB
has been suggested to have a role in general transcription
as a positive elongation factor, but it has also recently
been implicated in specific transcription regulation after
oxidative stress (Kyng et al. 2003), and the cellular CSB
status influences the transcript and protein level of OGG1
(Tuo et al. 2002a). It is not known how CSB mediates
these gene-specific effects, but it appears to be in an ATP-
independent manner. CSB nucleosome remodeling is
therefore most probably not involved.
Little is known about the mechanisms of action of
SNF2 family members. A DNA-tracking model resulting
in dissociation of all attached proteins has been tested
and rejected for MOT1 (Auble and Steggerda 1999).
Rather, MOT1 appears to be distributively recruited to
TBP bound to DNA (Auble and Steggerda 1999). SWI/
SNF is also recruited to certain promoters through pro-
tein interactions. The interaction of CSB with elongating
RNA Pol II and the lack of visible redistribution after
DNA damage could suggest that CSB is constitutively
associated with transcribing polymerases. The results
from MOT1 suggest that the SNF2 region is unfit to track
DNA and that CSB may bind to only the hyperphos-
phorylated CTD of RNA Pol II and not to DNA during
elongation. However, when the polymerase is stalled by
RNA secondary structure, natural pause sites, or a DNA
lesion, the polymerase-DNA interface changes, possibly
allowing CSB to interact with the polymerase and to bind
DNA at the same time. The DNA-mediated stimulation
of its ATPase activity could lead to ATP hydrolysis, and
the resulting conformational change could then change
the interaction between the polymerase and DNA, with
CSB as the connecting lever. The same mechanism could
account for nucleosome-remodeling activity employment
at stalled transcription complexes. The changed histone-
DNA interactions could allow DNA repair and/or tran-
scription resumption by opening up the chromatin, mak-
ing possible NER and transition from the smaller stalling
bubble to the larger elongation bubble.
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The ISWI-containing CHRAC complex associates with
a topoisomerase II (MIM 126430) dimer that is thought
to be implicated in the nucleosome-remodeling activity
(Travers 1999). Interaction with topoisomerases could
be a means for CSB to change the DNA twist and
thereby facilitate changes in DNA-histone interactions.
RAD5, the SNF2-family member involved in postrep-
lication repair, is part of a complex which polyubiqui-
tinates monoubiquitinated PCNA, resulting in error-free
DNA repair (Pickart 2002).
A Tentative Model for the Function of CSB
in Humans
On the basis of data reviewed above and models pre-
viously suggested for the actions of CSB, a tentative and
speculative model is developed and explained below (fig.
4).
CSB is implicated in RNA Pol I-, II-, and possibly III-
dependent transcription. It is suggested to stimulate
elongation when an RNA polymerase is paused at nat-
ural pause sites or by strong RNA secondary structure.
CSB is also important in preventing UV-induced ap-
optosis, most likely through a pivotal role in TC-NER.
The necessity of CSB in TC-NER results in increased
sensitivity of CSB-deficient cells toward damaging
agents that introduce bulky lesions and adducts capable
of blocking elongating RNA polymerases. A part of the
role of CSB in TC-NER is the removal of RNA poly-
merase II by ubiquitination and proteasomal degrada-
tion of the large subunit. This degradation may be nec-
essary for the cellular recovery of RNA synthesis after
polymerase-blocking damage to DNA, whether or not
the inflicted lesions are normally removed by TCR or
GGR. Even lesions normally removed by GGR, which
can be introduced in DNA by 4-NQO and NA-AAF,
can be expected to block some elongating polymerases
before being removed. The release of these polymerases,
partly through proteasomal degradation, can be as-
sumed to be important for allowing repair and the re-
sumption of RNA synthesis.
CSB can be isolated in large complexes with either
RNA polymerase I or II. It appears to specifically as-
sociate with the elongating hyperphosphorylated form
of RNA polymerase II. This, combined with the ap-
parent lack of redistribution of CSB after damage in-
duction, suggests that CSB is constitutively associated
with transcribing RNA polymerases. The SNF2-like do-
main appears incapable of DNA tracking, as shown for
MOT1, so CSB most probably does not interact with
DNA during elongation. However, when the polymer-
ase is paused or stalled, it backtracks, and its interface
with DNA changes. This could allow CSB to bind DNA,
which would stimulate its ATPase activity. Christiansen
et al. (2003) show that the ATPase activity of CSB is
most strongly stimulated by dsDNA with a small bubble
or loop reminiscent of a stalled transcription bubble
(Christiansen et al. 2003). Thus, CSB can be speculated
to bind DNA at the dsDNA-to-ssDNA transition of the
stalled transcription bubble, possibly behind the RNA
polymerase. The ATPase activity is necessary for the role
of CSB in TCR and is increased by dephosphorylation
of CSB in response to UV irradiation. The energy re-
leased from ATP hydrolysis is most likely used to change
the RNA polymerase-DNA interface. This might be
achieved through conformational changes in CSB,
which, owing to the fixation of CSB to DNA and its
simultaneous interaction with RNA polymerase, propa-
gates to change the DNA interaction of the polymerase.
As suggested for Mfd, CSB might pull the DNA through
the RNA polymerase, thereby pushing it forward (Park
et al. 2002). The pulling effect could be achieved by
DNA rewinding upstream of the RNA polymerase (Park
et al. 2002), an interesting putative function for a pro-
tein originally supposed to have helicase activity. The
forward pushing of RNA polymerase can be speculated
to release it from the backtracked position and thus to
resume elongating, if the stalling were due to nonblock-
ing causes. However, if the forward movement is
blocked by, for instance, a CPD, it can be suspected to
result in either a return to the backtracked position or a
changed conformation of the RNA polymerase. This pro-
longed backtracking or a changed conformation could
serve as a signal for TCR. Under the supposition that
the RNA polymerase is close to the lesion and hindering
repair, a natural beginning of the TCR would be the
recruitment of a ubiquitinating activity, such as the CSA-
containing complex. This would, through degradation,
remove the RNA polymerase and allow CSB—still bound
to DNA and possibly keeping the DNA open—to recruit
NER factors. The recruitment might be mediated through
the interaction of CSB and CSA with XAB2, which also
interacts with the damaged DNA-binding early NER
factor, XPA. A lack of CSB or CSA hinders the ubi-
quitination of blocked RNA polymerase. It is possible
that a factor, such as HuF2, can displace the RNA poly-
merase from DNA. However, if the RNA polymerase
remains stalled, it will result in apoptosis, either through
a p53-mediated pathway or through S phase entry and
progression.
The discovery of DNA polymerases capable of trans-
lesion synthesis (Friedberg and Gerlach 1999) has
prompted speculations regarding the putative existence
of a related function in RNA polymerases. This, as de-
scribed above, has also been suggested by the translo-
case activity of both the Mfd and the RSC complexes.
Also, a study of yeast shows that Rad26 promotes tran-
scription through methyl methanesulfonate–damaged
bases, normally removed by BER (Lee et al. 2002b). It
can be speculated that CSB is involved in stimulating
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Figure 4 Tentative model for CSB function in transcription and TCR. (See text for further explanation.)
transcription through minor base lesions, such as 8-
oxoA and 8-oxoG, by use of the same mechanism sug-
gested for naturally paused, backtracked RNA polymer-
ases. Preventing prolonged polymerase stalling would
increase the cellular resistance to oxidative damage.
The role of XPB, XPD, and XPG in this model, in
relation to the XP/CS phenotype, is also speculative.
Their involvement in the TC-NER reaction is no dif-
ferent from that of GG-NER, which is deficient in pa-
tients with classical XP with mutated XPD or XPG,
and thus cannot explain the CS-related symptoms. The
isolation of these three factors in a large complex with
CSB and RNA Pol I at physiological salt concentrations
suggests that they may be constitutively associated with
transcribing RNA Pol I. It is possible that the putative
translesion-stimulating effect of CSB past oxidatively
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modified bases is specific for RNA Pol I. This might be
an advantage for the high level of rRNA synthesis nec-
essary for cell growth and function. Also, the possibility
of incorporating mismatched bases during translesion
transcription might be less devastating in rRNA than
in mRNA, given that rRNA consists of both structural
and “coding” bases. Thus, a lack of this translesion
activity would sensitize a cell to oxidative damage, af-
fecting most strongly the rRNA synthesis and, therefore,
cellular growth. The specific roles of XPB, XPD, and
XPG in this complex can also only be speculated on.
As discussed above, the endonuclease activity of XPG
appears not to be important for the XPG/CS phenotype.
It is possible that the role of XPG in the RNA Pol I
complex is participation in stabilizing protein interac-
tions. However, XPG is also reported to stimulate BER
by stimulating the incision activity of the Nth1 glyco-
sylase. This might be mediated by a recruitment of DNA
glycosylases by XPG to the translesion synthesis site.
The role of XPB and XPD in this putative CSB function
could be the use of their helicase activity to open the
minor bubble of a stalled transcription complex to the
larger transcription-elongation bubble. By opening the
dsDNA in front of the RNA polymerase, XPB and XPD
would support the forward-translocating effect of the
CSB DNA-rewinding behind the polymerase.
CSB also has a role in transcription regulation after
oxidative stress and has an effect on GG-BER. This might
be mediated by entirely different mechanisms than those
described above and most likely does not require ATPase
activity. It is possible that a free fraction of CSB is modi-
fied in response to oxidative stress and thereby activated
to induce transcription of a specific set of genes impor-
tant for the stress response. The acidic region of CSB
could function as an N-terminal activation domain sep-
arated from the DNA-binding domain by the glycine-
rich stretch. The specificity of activation could be me-
diated by protein interactions with other transcription
factors. Thus, CSB would function as a coactivator, as
reported for the SNF2-like factor SRCAP. By inducing
transcription of genes encoding DNA glycosylases such
as OGG1 and UNG, CSB indirectly stimulates GG-BER.
All CSB-influenced pathways are affected to a com-
mon end by a deficient CSB protein: stalled RNA poly-
merases. This inhibits transcription and leads to ap-
optosis. Thus, cellularity and cellular growth are both
inhibited, providing a possible explanation for the low
cancer risk in patients with CS. Over time, a high cell-
death rate and inhibited growth can be expected to af-
fect nondividing tissues significantly and to empty the
stem cell pools of the body, resulting in reduced growth,
functional defects, and general atrophy in the patients.
Perspectives
The multisystem character of CS and the complexity of
the genotype-phenotype relationship suggest that the un-
derlying gene products are involved in basal cellular pro-
cesses. Through the participation of CSB in several direct
and functional protein interactions, the CS phenotype
becomes sensitive to genetic variation affecting concen-
tration, activity, and structure of its many interaction
partners. The recent finding that CSB is involved not
only in transcription and TCR by RNA Pol II but also
in transcription by RNA Pol I adds to its general basal
role in transcription. In yeast, RNA Pol I–transcribed
genes are subject to TCR (Conconi et al. 2002). The
implication of the CSB homologue Rad26 has not yet
been investigated. Apart from RNA Pol I and II, CSB
has indirectly been implicated in transcription by RNA
Pol III. Together, these results suggest a general role for
CSB in transcription and TCR by RNA Pol I, II, and
III. Such generality could be mediated by the interaction
of CSB with common subunits of the RNA polymerases.
A further extrapolation of these speculations leads to
the question of CSB involvement in mitochondrial
transcription.
The role of CSB in TCR has typically been studied
using exogenous DNA-damaging agents, such as UV
and cisplatin. However, UV irradiation does not pene-
trate the skull and therefore cannot be causative of the
neurological symptoms of CS. Candidates for natural
endogenous DNA lesions possibly repaired by TCR are
the cyclo-purines—cyclo-dA and cyclo-dG—which can
be induced by free radicals and are capable of blocking
RNA Pol II transcription (Brooks et al. 2000). The role
of CSB in GG-BER could also explain some of the sub-
cutaneous symptoms of CS.
CSB has been studied at phenotypic, cellular, subcel-
lular, and biochemical levels. Recently, several structure-
function studies have aided in integrating the knowledge
of these different levels. However, the question of the
control of CSB itself is as yet unresolved. Given the
involvement of CSB in several different processes, it can
be suspected that the participation of CSB in each pro-
cess is somehow interregulated in response to DNA dam-
age, development, cellular differentiation, and aging.
Also, the expression of CSB could vary during devel-
opment, differentiation, and aging and between differ-
ent tissues. It could be interesting to establish a tran-
scriptional profile of CSB and to study it in comparison
with profiles of CSA, XPB, XPD, and XPG. Also, a
comparison of the promoters of these CS-causative genes
might suggest common transcriptional regulators. The in-
terregulation of CSB among different cellular processes
is most likely of a posttranslational nature. CSB is dif-
ferentially phosphorylated in response to UV irradiation,
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and other posttranslational modifications might also be
involved. CSB could also be regulated, at the protein
level, through changes in quaternary structure and/or
through changes in protein-interaction partners. To in-
vestigate this, it would be interesting to map the inter-
action domains of CSB with the different interaction
partners and to see if the different areas overlap with
each other or with a putative additional CSB-binding
site. Such studies, and structure-function studies in gen-
eral, would be profoundly aided by having the CSB
tertiary structure solved.
An understanding of the processes and factors con-
trolling expression, activity, and choice of pathway by
CSB in response to different cellular stages and condi-
tions will help explain the CS phenotype. It will also
provide specific factors to pay attention to in comparing
the genetic backgrounds of patients with CS. It could
be especially rewarding to compare, using microarray
or probing for specific key factors, the CS-affected pa-
tients with identical mutations in CSB who display dif-
ferent symptoms with respect to genetic background. A
further characterization of the several functions of CSB
and the underlying mechanisms employed will also con-
tribute to the understanding of general processes of DNA
metabolism.
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